Members Trust’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
2,524
-65
-3% -$7.5K 0.01% 126
2026
Q1
$309K Hold
2,589
0.01% 116
2025
Q4
$353K Buy
2,589
+14
+0.5% +$2.01K 0.01% 107
2025
Q3
$380K Buy
2,575
+120
+5% +$16.6K 0.01% 102
2025
Q2
$318K Hold
2,455
0.01% 106
2025
Q1
$293K Sell
2,455
-340
-12% -$42.1K 0.01% 104
2024
Q4
$324K Sell
2,795
-75
-3% -$9.48K 0.01% 94
2024
Q3
$388K Hold
2,870
0.01% 81
2024
Q2
$389K Hold
2,870
0.01% 80
2024
Q1
$371K Hold
2,870
0.01% 82
2023
Q4
$328K Hold
2,870
0.01% 88
2023
Q3
$261K Hold
2,870
0.01% 94
2023
Q2
$323K Buy
+2,870
New +$304K 0.01% 86
2022
Q4
Sell
-2,900
Closed -$253K 111
2022
Q3
$253K Hold
2,900
0.01% 91
2022
Q2
$227K Hold
2,900
0.01% 102
2022
Q1
$247K Hold
2,900
0.01% 104
2021
Q4
$348K Hold
2,900
0.01% 89
2021
Q3
$371K Sell
2,900
-125
-4% -$16.1K 0.01% 83
2021
Q2
$363K Sell
3,025
-135
-4% -$15.4K 0.01% 90
2021
Q1
$332K Sell
3,160
-100
-3% -$10.1K 0.01% 86
2020
Q4
$332K Buy
+3,260
New +$306K 0.01% 85

Other funds holding XYL

Members Trust's XYL Position: Q2 2026 in Review

Members Trust reduced its Xylem (XYL) stake by 2.5% in Q2 2026, selling an estimated $7.5K and leaving 2,524 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #126.

Members Trust first reported a position in XYL in Q4 2020 and has held it in 21 quarters since. The position peaked at $389K in Q2 2024. 431 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Members Trust held 2,524 shares of Xylem worth $298K as of Q2 2026.
  • Members Trust sold 65 Xylem shares in Q2 2026, an estimated $7.5K.
  • Xylem made up 0.01% of Members Trust's portfolio in Q2 2026, its #126 holding.
  • Members Trust first reported a position in Xylem in Q4 2020 and has held it in 21 quarters since.
  • Members Trust's Xylem position peaked at $389K in Q2 2024.
  • 431 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Members Trust's 13F filing for Q2 2026, filed 31 Jul 2026.